You are right about Qsymia, but you are comparing apples with oranges. Companies spend millions of dollars per minute to advertise during the Super Bowl because advertising works. It will work for Belviq also. Also, take into consideration VVUS inability to find a marketing partner. ARNA doesn't have that problem because those envolved in the actual business of running a Biotech Company, and understand the science are not swayed by the hype, and they deal in facts. Perhaps you are right about "Easy Money" but easy money is for those looking for deals on buying a Gold Mine, not those willing to work it and live off the results.. So, even though they are both diet drugs, their circumstances couldn't be more different. AJMO.